✦ LIBER ✦

Pre-clinical evidence for the use of phosphodiesterase-5 inhibitors for treating benign prostatic hyperplasia and lower urinary tract symptoms

✍ Scribed by Hanna Tinel; Beatrix Stelte-Ludwig; Joachim Hütter; Peter Sandner

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Is there a rationale for the chronic use

✍ Thierry Roumeguère; K. Zouaoui Boudjeltia; Claude Hauzeur; Claude Schulman; Mich 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 166 KB

The use of PDE5 inhibitors in the treatm

✍ Peter Sandner; Hanna Tinel; Beatrix Stelte-Ludwig; Erwin Bischoff; Joachim Huett 📂 Article 📅 2007 🏛 BioMed Central 🌐 English ⚖ 192 KB

Combination 5-α-reductase inhibitors and

✍ Joseph C. Clarke; Timothy R. Yoost; Harry S. Clarke 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 162 KB

Combination 5-α-reductase inhibitors and

✍ Joseph C. Clarke; Timothy R. Yoost; Harry S. Clarke 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 218 KB

Pharmacological therapy of benign prosta

✍ Christopher R. Chapple 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB

Combination of phosphodiesterase-5 inhib

✍ CULLEY C. CARSON 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB